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034: Genetic determinants of Parkinson’s disease:
Insights from multiple gene analysis
B. K. Thelma
University of Delhi South Campus, Benito Juarez Road,
New Delhi 110021, India
The etiopathology of sporadic Parkinson’s disease (PD) remains
elusive due to complex interaction between genes and environmental
factors. Genes from dopaminergic, xenobiotic metabolism, oxidative
stress, apoptosis, and inflammatory and other pathways have been
commonly implicated. But results from large number of association
studies on these genes have been confounding. On the other hand
seven genes namely—alpha-synuclein (SNCA, PARK1), Parkin
(PARK2), UCHL1 (PARK5), PINK1 (PARK6), DJ1 (PARK7),
LRRK2 (PARK8) and ATP13A2 (PARK9) identified in monogenic
forms of PD provide considerable insight into cellular mechanisms
underlying the degeneration of nigral dopaminergic neurons. Con-
sidering neuronal cell death is the basic pathophysiology underlying
all forms of PD, our goals were to investigate the contribution of a)
candidate genes from multiple pathways, b) mutations and SNPs/
SNP haplotypes in familial PD genes and c) to test epistatic gene
interactions, to the etiology of sporadic PD. We examined 72
functional/non-synonymous/commonly investigated polymorphisms
in 30 candidate genes from multiple pathways mentioned above
using a case control approach in two independent cohorts, one from
south India (SI, n = 148 cases, 130 controls) and another from north
India (NI, n = 339 cases, 344 controls). Of the several significant
associations observed in this study, most promising were allelic/
genotypic/haplotypic associations of DRD4, DBH, NAT2 and
NQO1 gene variants. DRD4 and NAT2 significance were also
retained when the samples were re-grouped based on age of onset of
illness. As for the mutations in familial PD genes, there is negligible
contribution of alpha-synuclein, UCHL1, and LRRK2 in our popu-
lation but several novel and known mutations were observed in
Parkin, PINK1 and DJ1 genes contributing to different extents to
early onset PD. Results of association analysis of 16 SNPs from
these three and alpha-synuclein genes suggest their significant con-
tribution to genetics of sporadic PD. Several SNPs/SNP haplotypes
were associated but they were distinctly different between early and
late onset PD cases. These need to be explored further at a func-
tional level.
035: Integrative approaches to the identification
of genes involved in brain structure and function
John Blangero
Southwest Foundation for Biomedical Research, 7620 NW Loop,
San Antonio 78227, Texas, United States of America
The human brain is an enormously complex organ. Variation in brain
anatomy and function is now known to play an important role in the
determination of risk of many neuropsychiatric diseases. In this talk, I
will first provide an integrative paradigm for the joint utilization of
genomic and transcriptomic information that allows for the rapid
identification of genes involved in complex diseases. As a specific
example, the approach will be applied to the search for causal genes
involved in human brain structure/function. I will describe a unique
data resource, the San Antonio-based ‘‘Genetics of Brain Structure
and Function Study’’, for which genome-wide association data and
lymphocyte-based transcriptional profiles are being jointly used to
identify causal genes influencing brain anatomy and neurocognition.
Multiple brain structural phenotypes have been obtained using high
resolution magnetic resonance imaging. Similarly, extensive neuro-
cognitive testing has been employed to obtain objective measures of
brain function. High-dimensional endophenotype identification using
large-scale transcriptional profiling has revealed a large number of
genes whose expression levels correlate with various aspects of
neurofunction. When combined with genome-wide association data,
we use this method to identify novel empirically-justified candidate
genes for more exhaustive genetic analysis. Similarly, the approach
can be used to identify upstream regulators and downstream targets of
known candidate genes whose functions are incompletely understood.
As an example of this type of usage, I will provide new data on the
DISC1 gene, an important candidate in several psychiatric disorders.
036: Genomic variation and cancer
1,2T. J. Hudson, On behalf of the ARCTIC Project Investigators and
the International Cancer Genome Consortium
1Ontario Institute for Cancer Research, Toronto, Canada, 2McGill
University and Genome Quebec Innovation Centre, Montreal, Canada
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Genomic variation, through its effect on gene structure and expres-
sion, plays an important role in disease predisposition, biology, and
clinical response to therapy. Cancer mutations can be classified as
germline (inherited) and somatic (tumoral). I will provide examples of
ongoing projects in my laboratory that are pertinent to both classes of
cancer mutations. Recent studies of genetic variation across the
human genome have led to concepts for a systematic approach to
study a large fraction of human genes, using strategies that exploit
linkage disequilibrium. In the first part of my talk, I will describe a
project called ARCTIC (Assessment of Risk for Colorectal Tumours
in Canada) which is designed to identify genetic variants predisposing
to colorectal cancer. Employing a multi-stage genome-wide associa-
tion strategy involving 7480 cases and 7779 controls, we identified
several loci associated with colorectal cancer. I will focus on a locus
on chromosomes 8q, which has also been implicated in prostate
cancer, suggesting the possibility of a role in a broad spectrum of
cancers. Current efforts in my laboratory at this and other loci are
aimed at narrowing the search for the causal variants, and involve
next-generation sequencing of templates generated using array-based
selection strategies. In April 2008, representatives from Australia,
Canada, China, France, India, Japan, Singapore, the United Kingdom,
the United States, and the European Commission announced the
launch of the International Cancer Genome Consortium (ICGC)
which has been organized to coordinate a large number of projects
that have the common aim of elucidating comprehensively the
genomic changes present in many forms of cancers that contribute to
the burden of disease in people throughout the world. The primary
goals of the ICGC are to generate comprehensive catalogues of
genomic abnormalities (somatic mutations, abnormal expression of
genes, epigenetic modifications) in tumors in 50 different cancer types
and/or subtypes and make the data available to the research com-
munity as rapidly as possible, and with minimal restrictions, to
accelerate research into the causes and control of cancer. In addition
to presenting the goals, structure and policies of the consortium, I will
describe the design and early results from the pancreatic cancer
genome team at the Ontario Institute for Cancer Research.
037: Genetics of Restless legs syndrome
Thomas Meitinger
Institute of Human Genetics, D-85764 Neuherberg, Germany
The Restless legs syndrome (RLS) is a common neurological disorder
with an age dependent prevalence up to 10% in the elderly. Since the
first description of the symptoms a large genetic contribution in the
aetiology was suspected. Up to 40–60% of idiopathic RLS patients
have a positive family history. Linkage analysis in large RLS families
uncovered five loci based on a recessive (RLS1) or dominant inher-
itance (RLS2–RLS5). A genome-wide association study with samples
from 1600 RLS patients and 2600 controls of the general population
(KORA) was conducted. Individuals originated from Germany,
Austria and French Canada. Four chromosomal regions have been
identified with signals within the genes MEIS1, BTBD9, LBXCOR1
and PRPRD. The MEIS1 associated SNPs are located in a region of
high interspecies conservation. The attributable risk fraction esti-
mated for the four loci was higher than 50% for the populations
studied. A comparison of familial versus sporadic cases demonstrated
very similar results. The identified genes MEIS1 and LBXCOR1 are
known as control factors in embryonic development. PTPRD belongs
to the family of type IIa receptor-like protein tyrosine phosphatases
and functions in axon guidance and termination of mammalian mo-
torneurons during embryonic development.
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